New trial tests two drug combos to keep advanced breast cancer in check
NCT ID NCT07179939
Summary
This study is testing two different maintenance drug combinations to help control advanced HER2-positive breast cancer after initial treatment. Researchers want to see which approach works better to delay cancer progression based on patients' hormone receptor status. The trial will enroll 288 women with advanced breast cancer that cannot be surgically removed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fudan University
Shanghai, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.